H-SAPDTRPA-OH

Ref. 3D-PP46903

Product Information

• Name: H-SAPDTRPA-OH
• Synonyms: NH2-Ser-Ala-Pro-Asp-Thr-Arg-Pro-Ala-OH

Description

Peptide H-SAPDTRPA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SAPDTRPA-OH include the following: Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine W Qi, BC Schultes, D Liu, M Kuzma - Hybridoma and , 2001 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/15368590152740716 Optical detection of CA 15.3 breast cancer antigen using CdS quantum dot V Elakkiya , MP Menon, D Nataraj , P Biji - Iet , 2017 - Wiley Online Libraryhttps://ietresearch.onlinelibrary.wiley.com/doi/abs/10.1049/iet-nbt.2016.0012 Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design V Apostolopoulos , IF McKenzie, IA Wilson - Front Biosci, 2001 - article.imrpress.comhttps://article.imrpress.com/bri/Landmark/articles/pdf/LandmarkA683.pdf Vaccine Development Against Novel Breast Cancer Antigens V Apostolopoulos , I McKenzie - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA409560 A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor V Apostolopoulos , E Yuriev - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2432220100 Noncanonical peptides in complex with MHC class I V Apostolopoulos , E Lazoura - Expert Review of Vaccines, 2004 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/14760584.3.2.151 Non-canonical peptides bound to MHC SL Day, PA Ramsland - Current pharmaceutical , 2009 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2009/00000015/00000028/art00007 Design of enhanced agonists through the use of a new virtual S Madurga, I Belda , X Lloraca , E Giralt - 2005 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=1f1845a0a6cf273040d7ab359cea1339a39316d7 Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccines S Koido, Y Enomoto, V Apostolopoulos - Anticancer , 2014 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/34/8/3917.short Anti-mucin monoclonal antibodies PX Xing, V Apostolopoulos , G Pietersz, IF McKenzie - Front Biosci, 2001 - researchgate.nethttps://www.researchgate.net/profile/Vasso-Apostolopoulos/publication/11769574_Anti-mucin_monoclonal_antibodies/links/53e4b8e20cf25d674e94e319/Anti-mucin-monoclonal-antibodies.pdf Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses P Karmakar , K Lee, S Sarkar, KA Wall - Bioconjugate , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.5b00528 Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen P Beatty, S Ranganathan, OJ Finn - Oncoimmunology, 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/onci.18950 The good, the bad and the ugly: how altered peptide ligands modulate immunity M Katsara, G Minigo , M Plebanski - Expert opinion on , 2008 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/14712590802494501 MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast M Gad, T Jensen, R Gagne, S Komba - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200323698 Aberrant glycosylation of anchor-optimized MUC1 peptides can enhance antigen binding affinity and reverse tolerance to cytotoxic T lymphocytes LB Pathangey, V Lakshminarayanan, VJ Suman - Biomolecules, 2016 - mdpi.comhttps://www.mdpi.com/2218-273X/6/3/31 Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine L Ding, EN Lalani, M Reddish , R Koganty - Cancer Immunology , 1993 - Springerhttps://link.springer.com/article/10.1007/BF01789125 The effect of the branched chain polypeptide carrier on biodistribution of covalently attached B-cell epitope peptide (APDTRPAPG) derived from mucin 1 glycoprotein K Uray , MV Pimm, F Hudecz - Archives of biochemistry and biophysics, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003986118306568 Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-beta2 microglobulin complexes JA Atzin-Mendez, JS Lopez-Gonzalez - Oncology , 2016 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.2015.4328?text=abstract Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope J Singh, C Her, N Supekar , GJ Boons - Journal of Peptide , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3229 Synthesis and conformational features of human salivary mucin C-terminal derived peptide epitope carrying Thomsen-Friedenreich antigen: Implications for its role in J Satyanarayana, TL Gururaja - Biopolymers , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1097-0282(20010415)58:5%3C500::AID-BIP1025%3E3.0.CO;2-5 T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1 J Gong, B Zhu, A Murshid , H Adachi - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/183/5/3092/103794 Naturally presented MHC ligands carrying glycans J Dengjel , S Stevanovic - Transfusion Medicine and Hemotherapy, 2006 - karger.comhttps://karger.com/tmh/article-abstract/33/1/38/300631 Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine FG Hanisch, T Ninkovic - Current Protein and Peptide Science, 2006 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpps/2006/00000007/00000004/art00004 Immunology of MUC1 and Advancements in the Development of MUC1 Glycopeptide Tumor Vaccines: An Update FG Hanisch - researchgate.nethttps://www.researchgate.net/profile/Franz-Georg-Hanisch/publication/271133546_Immunology_of_MUC1_and_Advancements_in_the_Development_of_MUC1_Glycopeptide_Tumor_Vaccines_An_Update/links/54be57210cf218da9391e5d9/Immunology-of-MUC1-and-Advancements-in-the-Development-of-MUC1-Glycopeptide-Tumor-Vaccines-An-Update.pdf Insights into peptide-based vaccine design for cancer immunotherapy E Lazoura, V Apostolopoulos - Current medicinal chemistry, 2005 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2005/00000012/00000013/art00003 Non-canonical anchor motif peptides bound to MHC class I induce cellular responses E Lazoura, J Lodding, W Farrugia, S Day - Molecular , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589008007578 major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide E Lazoura, J Lodding, W Farrugia, PA Ramsland - , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2006.02434.x Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation D Weng, B Song, S Koido, SK Calderwood - The Journal of , 2013 - journals.aai.orghttps://journals.aai.org/jimmunol/article/191/2/755/83709 Molecular dynamics simulations of the O-glycosylated 21-residue MUC1 peptides A Rubinstein, L Kinarsky, S Sherman - International journal of molecular , 2004 - mdpi.comhttps://www.mdpi.com/1422-0067/5/4/119 Investigating receptors for extracellular heat shock proteins A Murshid , J Theriault, J Gong - Chaperones: Methods and , 2011 - Springerhttps://link.springer.com/protocol/10.1007/978-1-61779-295-3_22

• Brand: Biosynth